Open original FDA record ↗Recall record
- FDA identifier
- Z-2299-2016
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc.
- FDA classification date
- Jul 28, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Siemens Healthcare Diagnostics has confirmed the Syva EMIT 2000 Theophylline reagent lot G3, when run on a Beckman AU Clinical Chemistry System, and the ADVIA Chemistry Theophylline_2 (THEO_2) reagent lot 334018, may exhibit increased imprecision for commercially available Bio-Rad Liquichek TDM Quality Control Levels and patient samples
Source facts
- Action
- Siemens Healthcare Diagnostics mailed a letter to customers on June 17, 2016, asking that they discontinue use of and discard the affected kit lots identified in the recall notification letter. Customers were also asked to complete and return the Field Correction Effectiveness Check/Product Replacement Form that was mailed with the Recall Notification Letter.
- Initiated
- 2016-06-17
- Root cause
- Process control
- Terminated
- 2017-03-15
- Distribution
- Distributed to: CA, CT, DE, FL, GA, IA, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NM, NY, OH, OK, PA, TN, VA, WA
- Recall number
- Z-2299-2016
- Recall status
- Terminated
- CDRH record ID
- 147834
- FDA classified
- 2016-07-28
- Recall event number
- 74524